Home › Entities › academia › Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab

Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab

Research article (Proceedings of the National Academy of Sciences, 2017) · cited 160× · AI/ML
academia openalex:W2614002306
Press Enter · cited answer in seconds

Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab

Summary

Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab is a scholarly article[1].

Key Facts

  • Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab's instance of is recorded as scholarly article[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab. Retrieved May 24, 2026, from https://4ort.xyz/entity/structural-basis-for-cancer-immunotherapy-by-the-first-in-class-checkpoint-inhibitor-ipilimumab
MLA “Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.” 4ort.xyz Knowledge Graph, 4ort.xyz, 24 May. 2026, https://4ort.xyz/entity/structural-basis-for-cancer-immunotherapy-by-the-first-in-class-checkpoint-inhibitor-ipilimumab.
BibTeX @misc{4ortxyz_structural-basis-for-cancer-immunotherapy-by-the-first-in-class-checkpoint-inhibitor-ipilimumab_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab}}, year = {2026}, url = {https://4ort.xyz/entity/structural-basis-for-cancer-immunotherapy-by-the-first-in-class-checkpoint-inhibitor-ipilimumab}, note = {Accessed: 2026-05-24}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab — https://4ort.xyz/entity/structural-basis-for-cancer-immunotherapy-by-the-first-in-class-checkpoint-inhibitor-ipilimumab (retrieved 2026-05-24)

Canonical URL: https://4ort.xyz/entity/structural-basis-for-cancer-immunotherapy-by-the-first-in-class-checkpoint-inhibitor-ipilimumab · Last refreshed: